Vanda Pharmaceuticals Inc (VNDA): Next-Year EPS Estimate 62.03%
As of 2026-06-11, Vanda Pharmaceuticals Inc (VNDA) has a next-year EPS growth estimate of 62.03%.
On 2026-05-11, analyst consensus for VNDA's next-year EPS growth shifted from 59.30% to 62.03% — a positive change of 2.73 percentage points. The revised estimate has been sustained across 24 subsequent trading sessions. Current-year growth is projected at 38.45%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 62.03%
- EPS growth this year
- 38.45%
- EPS next quarter (est)
- -$0.60
- Last price
- $6.10
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 62.03% | 38.45% | -$0.60 | $6.10 |
| 2026-06-10 | 62.03% | 38.45% | -$0.60 | $6.03 |
| 2026-06-09 | 62.03% | 38.45% | -$0.60 | $6.12 |
| 2026-06-08 | 62.03% | 38.45% | -$0.60 | $5.94 |
| 2026-06-07 | 62.03% | 38.45% | -$0.60 | $6.03 |
| 2026-06-04 | 62.03% | 38.45% | -$0.60 | $6.25 |
| 2026-06-03 | 62.03% | 38.45% | -$0.60 | $6.09 |
| 2026-06-02 | 62.03% | 38.45% | -$0.60 | $6.13 |
| 2026-06-01 | 62.03% | 38.45% | -$0.60 | $6.36 |
| 2026-05-31 | 62.03% | 38.45% | -$0.60 | $6.45 |
| 2026-05-28 | 62.03% | 38.45% | -$0.60 | $6.64 |
| 2026-05-27 | 62.03% | 38.45% | -$0.60 | $6.46 |
| 2026-05-26 | 62.03% | 38.45% | -$0.60 | $6.22 |
| 2026-05-25 | 62.03% | 38.45% | -$0.60 | $6.19 |
| 2026-05-24 | 62.03% | 38.45% | -$0.60 | $6.19 |
| 2026-05-21 | 62.03% | 38.45% | -$0.60 | $6.21 |
| 2026-05-20 | 62.03% | 38.45% | -$0.60 | $6.18 |
| 2026-05-19 | 62.03% | 38.45% | -$0.60 | $5.99 |
| 2026-05-18 | 62.03% | 38.45% | -$0.60 | $6.08 |
| 2026-05-17 | 62.03% | 38.45% | -$0.60 | $6.28 |
| 2026-05-14 | 62.03% | 38.45% | -$0.60 | $6.39 |
| 2026-05-13 | 62.03% | 38.45% | -$0.60 | $6.46 |
| 2026-05-12 | 62.03% | 38.45% | -$0.60 | $6.42 |
| 2026-05-11 | 62.03% | 38.45% | -$0.60 | $6.27 |
| 2026-05-10 | 59.30% | 40.21% | -$0.60 | $6.28 |
| 2026-05-07 | 60.04% | 42.19% | -$0.57 | $6.39 |
| 2026-05-06 | 65.14% | 40.32% | -$0.69 | $7.44 |
| 2026-05-05 | 65.14% | 40.32% | -$0.69 | $7.39 |
| 2026-05-04 | 65.14% | 40.32% | -$0.69 | $7.56 |
| 2026-05-03 | 65.14% | 40.32% | -$0.69 | $7.00 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Vanda Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Vanda Pharmaceuticals Inc (VNDA) has a next-year EPS growth estimate of 62.03%, based on analyst consensus.
When was the latest EPS estimate revision for VNDA?▾
The most recent revision occurred on 2026-05-11, when analysts adjusted the next-year EPS growth estimate from 59.30% to 62.03%.
What sector and industry does Vanda Pharmaceuticals Inc belong to?▾
Vanda Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. VNDA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Vanda Pharmaceuticals Inc (VNDA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports